NT-proBNP changes, oxidative stress, and energy status of hypertrophic myocardium following ischemia/reperfusion injury

Biomedicine and Pharmacotherapy

Volumn 61, Issue 2-3, 2007, Pages 160-166

  Scolletta, S ^a,b   Carlucci, F ^a,b   Biagioli, B ^a,b   Marchetti, L ^b   Maccherini, M ^b   Carlucci, G ^b   Rosi, F ^a   Salvi, M ^b   Tabucchi, A ^a,b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Ischemia reperfusion injury; Left ventricular myocardial hypertrophy; Natriuretic peptide

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOCHEMICAL MARKER;

ADULT; AGED; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; CAPILLARY ELECTROPHORESIS; CLINICAL ARTICLE; DISEASE MARKER; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENERGY METABOLISM; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE ISCHEMIA; HEMODYNAMIC PARAMETERS; HUMAN; MALE; OXIDATIVE STRESS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REPERFUSION INJURY; TREATMENT OUTCOME;

ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; CARDIOMYOPATHY, HYPERTROPHIC; ELECTROPHORESIS, CAPILLARY; ENERGY METABOLISM; EXTRACORPOREAL CIRCULATION; FEMALE; HEART ARREST, INDUCED; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; IMMUNOASSAY; LUMINESCENT MEASUREMENTS; MALE; MYOCARDIAL REPERFUSION INJURY; NATRIURETIC PEPTIDE, BRAIN; NITRATES; NITRITES; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; SEVERITY OF ILLNESS INDEX;

EID: 34147124255     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2006.10.007     Document Type: Article

References (25)

1. Braunwald E. Aortic stenosis. Heart disease: a textbook of cardiovascular medicine (1997), WB Saunders Co, Philadelphia 1035
2. Sagnella G.A. Measurements and significance of circulating natriuretic peptides in cardiovascolur diseases. (Review). Clin Sci 95 (1998) 519
3. Suzuki T., Yamazaki T., and Yazaki Y. The role of natriuretic peptides in the cardiovascular system. (Review). Cardiovasc Res 51 (2001) 489
4. Boomsma F., van den Meiracker A.H., and Plasma A.-. B-type natriuretic peptides: physiology, methodology and clinical use. Cardiovasc Res 51 (2001) 442
5. Yasue H., Yoshimura M., Sumida H., Kikuta K., Kugiyama K., Jougasaki M., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natruiretic peptide in normal subjects and patients with heart failure. Circulation 90 (1994) 195
6. Ikeda T., Matsuda K., Itoh H., Shirakami G., Miyamoto Y., Yoshimasa T., et al. Plasma levels of brain natriuretic peptide and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis. Am Heart J 133 (1997) 307
7. Hunt P.J., Yandle T.G., Nicholls M.G., Richards A.M., and Espiner E.A. The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun 214 (1995) 1175
8. Karl J., Borgya A., Gallusser A., Huber E., Krueger K., Rollinger W., et al. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. Scand J Clin Lab Invest Suppl 230 (1999) 177
9. Wollert K.C., and Drexler H. Regulation of cardiac remodeling by nitric oxide: focus on cardiac myocyte hypertrophy and apoptosis. Heart Fail Rev 7 (2002) 317
10. Amann K., and Tyralla K. Cardiovascular changes in chronic renal failure-pathogenesis and therapy. Clin Nephrol 58 Suppl 1 (2002) S62
11. Qi W., Mathisen P., Kjekshus J., Simonsen S., Bjornerheim R., Endresen K., et al. Natriuretic peptides in patients with aortic stenosis. Am Heart J 142 (2001) 725
12. Prasad N., Bridges A.B., Lang C.C., Clarkson P.B., MacLeod C., Pringle T.H., et al. Brain natriuretic peptide concentrations in patients with aortic stenosis. Am Heart J 133 (1997) 477
13. Talwar S., Downie P.F., Squire I.B., Davies J.E., Barnett D.B., and Ng L.L. Plasma N-terminal pro-BNP and cardiotrophin-1 are elevated in aortic stenosis. Eur J Heart Fail 3 (2001) 15
14. Levy D., Savage D.D., Garrison R.J., Anderson K.M., Kannel W.B., and Castelli W.P. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 59 (1987) 956
15. Buckberg G.D. Development of blood cardioplegia and retrograde techniques: the experimenter/observer complex. J Card Surg 13 (1998) 163
16. Buckberg G.D. Antegrade/retrograde blood cardioplegia to ensure cardioplegic distribution: operative techniques and objectives. J Card Surg 4 (1989) 216
17. Scolletta S., Romano S.M., Biagioli B., Capannini G., and Giomarelli P. Pressure Recording Analytical Method (PRAM) for measurement of cardiac output during various haemodynamic states. Br J Anaesth 95 (2005) 159
18. Biagioli B., Scolletta S., Marchetti L., Tabucchi A., and Carlucci F. Relationships between hemodynamic parameters and myocardial anergy and antioxidant status in heart transplantation. Biomed Pharmacoth 57 (2003) 156
19. Carlucci F., Tabucchi A., Biagioli B., Simeone F., Scolletta S., Rosi F., et al. Cardiac surgery: myocardial energy balance, antioxidant status and endothelial function after ischemia-reperfusion. Biomed Pharmacoth 56 (2002) 483
20. Avidan M.S., Meehan N., Ponte J., El-Gamel A., and Sherwood R.A. Changes in brain natriuretic peptide concentrations following open cardiac surgery with cardioplegic arrest. Clin Chim Acta 303 (2001) 127
21. Reyes G., Fores G., Rodriguez-Abella R.H., Cuerpo G., Vallejo J.L., Romero C., et al. NT-proBNP in cardiac surgery: a new tool for the management of our patients?. Int Cardiovasc Thorac Surg 4 (2005) 242
22. Gerber I.L., Stewart R.A.H., Legget M.E., West T.M., French R.L., Sutton T.M., et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 107 (2003) 1884
23. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Maeda Y., Fukai D., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96 (1997) 509
24. Hutfless R., Kazanegra R., Madani M., Bhalla M.A., Tulua-Tata A., Chen A., et al. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 43 (2004) 1873
25. Weber M., Arnold R., Rau M., Brandt R., Berkovitsch A., Mitrovic V., et al. Relation of N-Terminal pro-B-type natriuretic peptide to severità of valvular aortic stenosis. Am J Cariol 94 (2004) 740